Eurostars project Neo-Lung
|Coordinator||GPX MEDICAL AB|
|Funding from Vinnova||SEK 3 008 096|
|Project duration||October 2015 - December 2018|
Purpose and goal
The aim of the project has been to develop a medical technology system for the diagnosis of lungs in premature infants. These are often affected by complications in the lungs as these are not fully developed. To facilitate breathing, respirator is used in combination with drugs. Oxygenation and lung function are monitored by invasive methods and there is a need for continuous harmless monitoring. In the Neo-Lung project, a system has been developed based on a laser spectroscopic analysis technique and a pilot study on newborn healthy children has been performed.
Expected results and effects
A medical device with probes adapted for sensitive skin has been developed in consultation with physicians and has been approved for study at the local hospital. The measurement results confirm that the concept of measuring oxygenation with this technology is possible and that there are further technical improvements to be made. Cooperation with the industrial suppliers in the project was strengthened and several technical advances have been made. The project has generated 4 scientific articles / manuscripts, several conference contributions and master thesis projects.
Planned approach and implementation
It has been an intensive collaboration between the various project participants during the project. The division with work packages where different project participants have the main responsibility has been easy to follow up. The concept where each project participant reports the finances separately is very good. It has been a reasonable amount of project reporting to Eurostars and Vinnova.